Davis Polk advised MicroTech Medical, while Clifford Chance has advised the joint sponsors involved in the transaction.The Hangzhou-based firm offers diabetes therapy and manufactures medical devices…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
